Billionaire Ken Griffin Dumps Nvidia Stock, Loads up on Palantir

Full Article
Billionaire Ken Griffin Dumps Nvidia Stock, Loads up on Palantir

Ken Griffin, the billionaire CEO of Citadel, has made significant moves in the stock market, selling off a large portion of his Nvidia shares while investing heavily in Palantir. Despite the prevailing optimism surrounding AI advancements, Griffin expresses skepticism about AI's ability to outperform human capabilities in many scenarios. He believes that certain tasks, particularly those requiring adaptability to unpredictable conditions, are not suitable for AI models.

Griffin's decision to reduce his Nvidia holdings by 80% comes as the company faces challenges, including delays in the launch of its new AI chip. In contrast, his investment in Palantir reflects confidence in its growth potential, especially with its recent success in the commercial sector and the launch of its AI Platform. Analysts have mixed views on both companies, with Nvidia still holding a Strong Buy consensus while Palantir's outlook remains more cautious.

• Griffin sells Nvidia shares while investing in Palantir amid AI skepticism.

• Nvidia faces challenges with AI chip delays, impacting investor confidence.

Key AI Terms Mentioned in this Article

Generative AI

The article discusses concerns about generative AI's impact on job security and its efficiency compared to human work.

AI Platform

Palantir's AI Platform aims to streamline AI model deployment and has gained traction in the commercial sector.

Machine Learning

Griffin highlights that certain scenarios are not suitable for machine learning applications.

Companies Mentioned in this Article

Nvidia

Nvidia has established itself as a key player in the AI market, but faces challenges with recent product delays.

Palantir

Palantir is expanding its reach into the commercial sector with its AI Platform, which has shown significant growth.

Get Email Alerts for AI News

By creating an email alert, you agree to AIleap's Terms of Service and Privacy Policy. You can pause or unsubscribe from email alerts at any time.

Latest Articles

Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive
TechCrunch 6month

Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600

AI In Education - Up-level Your Teaching With AI By Cloning Yourself
Forbes 6month

How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.

Trump's Third Term - How AI Can Help To Overthrow The US Government
Forbes 6month

Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.

Sam Altman Says OpenAI Will Release an 'Open Weight' AI Model This Summer
Wired 6month

Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.

Popular Topics